Phase 1/2 Trial of AEF0217 in Participants With Down Syndrome
Condition(s):Down SyndromeLast Updated:January 31, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Down SyndromeLast Updated:January 31, 2024Recruiting
Condition(s):Marijuana AbuseLast Updated:April 7, 2023Completed
Condition(s):Marijuana AbuseLast Updated:January 31, 2024Active, not recruiting
Condition(s):Marijuana AbuseLast Updated:January 31, 2024Active, not recruiting
Condition(s):Safety, Tolerability, Pharmacokinetics of AEF0217Last Updated:February 1, 2024Completed
Condition(s):Marijuana AbuseLast Updated:June 2, 2021Completed
Condition(s):Healthy VolunteersLast Updated:June 19, 2018Completed
Condition(s):Healthy VolunteersLast Updated:March 13, 2018Completed
Condition(s):Down Syndrome; HealthyLast Updated:January 27, 2020Unknown status
Condition(s):Down SyndromeLast Updated:March 10, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.